Clinical trials
Completed trials in Portugal with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
502 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 8 |
| 2012 | 19 |
| 2013 | 7 |
| 2014 | 16 |
| 2015 | 21 |
| 2016 | 17 |
| 2017 | 31 |
| 2018 | 54 |
| 2019 | 45 |
| 2020 | 35 |
| 2021 | 56 |
| 2022 | 51 |
| 2023 | 46 |
| 2024 | 40 |
| 2025 | 29 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 502 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidade do Porto | 45 |
| Aveiro University | 34 |
| University of Coimbra | 30 |
| University of Évora | 15 |
| University of Lisbon | 14 |
| Egas Moniz - Cooperativa de Ensino Superior, CRL | 13 |
| Escola Superior de Tecnologia da Saúde do Porto | 12 |
| Faculdade de Motricidade Humana | 11 |
| University of Minho | 11 |
| University Fernando Pessoa | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 14 |
| Obesity | 13 |
| Cognitive Dysfunction | 12 |
| Dementia | 12 |
| Stroke | 12 |
| Coronary Artery Disease | 11 |
| Breast Neoplasms | 10 |
| Heart Failure | 9 |
| Pain | 9 |
| Pulmonary Disease, Chronic Obstructive | 8 |
Trials
Showing 1 to 25 of 502. Each trial links to its page on Pharma Observatory.
402 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.